chalcone has been researched along with Endotoxin Shock in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batt, DG; Covington, MB; Goodman, R; Jones, DG; Kerr, JS; Mantegna, LR; McAllister, C; Newton, RC; Nurnberg, S; Welch, PK | 1 |
Chen, H; Dai, Y; Huang, Y; Liang, G; Liu, X; Mei, L; Pan, Z; Shan, X; Wu, B; Xu, T; Zhang, Y | 1 |
Chang, YL; Cheng, ZJ; Guh, JH; Huang, YC; Hwang, TL; Lin, CN; Teng, CM | 1 |
3 other study(ies) available for chalcone and Endotoxin Shock
Article | Year |
---|---|
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis.
Topics: Animals; Cell Survival; Chalcone; Female; Humans; Interleukin-1; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Monocytes; Shock, Septic; Structure-Activity Relationship | 1993 |
Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Chalcone; Chalcones; Cytokines; Humans; Inflammation Mediators; Lipopolysaccharides; Lung; Lymphocyte Antigen 96; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Models, Molecular; Molecular Targeted Therapy; Protective Agents; RAW 264.7 Cells; Shock, Septic | 2017 |
Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells.
Topics: Animals; Antioxidants; Cell Line; Chalcone; Chalcones; Cyclooxygenase 2; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; I-kappa B Proteins; Immunohistochemistry; Isoenzymes; Lipopolysaccharides; Longevity; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Shock, Septic | 2001 |